speb/financial-data huggingface dataset:
CNRI.V cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1.00
CNRI.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 24213.00
CNRI.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6053.00
CNRI.V balance_sheet (annual, 2025-12-31) — Current Assets: 208519.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 208519.00
CNRI.V balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
CNRI.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 1045280.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1045280.00
CNRI.V cash_flow (annual, 2025-12-31) — Deferred Income Tax: -360179.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 28463.00
CNRI.V cash_flow (annual, 2025-12-31) — Deferred Tax: -360179.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: 28463.00
CNRI.V cash_flow (annual, 2025-12-31) — Depreciation: 24213.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Depreciation: 6053.00
CNRI.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 24213.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 6053.00
CNRI.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 24213.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 6053.00
CNRI.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 114333198.00
CNRI.V income_statement (annual, 2025-12-31) — Diluted EPS: -0.01
CNRI.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -263447.00
CNRI.V income_statement (annual, 2025-12-31) — EBIT: -1022720.00
CNRI.V income_statement (quarterly, 2025-12-31) — EBIT: -234984.00
CNRI.V income_statement (annual, 2025-12-31) — EBITDA: -998507.00
CNRI.V income_statement (quarterly, 2025-12-31) — EBITDA: -228931.00
CNRI.V cash_flow (annual, 2025-12-31) — End Cash Position: 12055.00
CNRI.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 12055.00
CNRI.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: -596168.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1.00
CNRI.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -1038003.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -15893.00
CNRI.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 935651.00
CNRI.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 211273.00
CNRI.V balance_sheet (annual, 2025-12-31) — Gross PPE: 49195744.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 49195744.00
CNRI.V income_statement (annual, 2025-12-31) — Gross Profit: -24213.00
CNRI.V income_statement (quarterly, 2025-12-31) — Gross Profit: -6053.00
CNRI.V income_statement (annual, 2025-12-31) — Interest Expense: 49325.00
CNRI.V income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
CNRI.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 49325.00
CNRI.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 0.00
CNRI.V income_statement (annual, 2025-12-31) — Interest Income: 9144.00
CNRI.V income_statement (quarterly, 2025-12-31) — Interest Income: 342.00
CNRI.V income_statement (annual, 2025-12-31) — Interest Income Non Operating: 9144.00
CNRI.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 342.00
CNRI.V balance_sheet (annual, 2025-12-31) — Invested Capital: 42625967.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 42625967.00
CNRI.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -624007.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -256556.00
CNRI.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CNRI.V balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
CNRI.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -519550.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
CNRI.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -76618.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1.00
CNRI.V income_statement (annual, 2025-12-31) — Net Income: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Income: -263447.00
CNRI.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -263447.00
CNRI.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -263447.00
CNRI.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -263447.00
CNRI.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -263447.00
CNRI.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -711866.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -263447.00
CNRI.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -263447.00
CNRI.V income_statement (annual, 2025-12-31) — Net Interest Income: -40181.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Interest Income: 342.00
CNRI.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -519550.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CNRI.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -519550.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
CNRI.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -40181.00
CNRI.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 342.00
CNRI.V balance_sheet (annual, 2025-12-31) — Net PPE: 45718049.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 45718049.00
CNRI.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -18000.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
CNRI.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 42625967.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 42625967.00
CNRI.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 2255321.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2255321.00
CNRI.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2255321.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2255321.00
CNRI.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -998507.00
CNRI.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -228931.00
CNRI.V income_statement (annual, 2025-12-31) — Normalized Income: -711866.00
CNRI.V income_statement (quarterly, 2025-12-31) — Normalized Income: -263447.00
CNRI.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -413996.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 240663.00
CNRI.V income_statement (annual, 2025-12-31) — Operating Income: -1031864.00
CNRI.V income_statement (quarterly, 2025-12-31) — Operating Income: -235326.00
CNRI.V income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
CNRI.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CNRI.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 114320317.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 114320317.00
CNRI.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 7714588.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 7714588.00
CNRI.V income_statement (annual, 2025-12-31) — Other Gand A: 813313.00
CNRI.V income_statement (quarterly, 2025-12-31) — Other Gand A: 180592.00
CNRI.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 49325.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 0.00
CNRI.V income_statement (annual, 2025-12-31) — Other Operating Expenses: 72000.00
CNRI.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 18000.00
CNRI.V balance_sheet (annual, 2025-12-31) — Other Properties: 49195744.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 49195744.00
CNRI.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1045280.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1045280.00
CNRI.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 138959.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 138959.00
CNRI.V income_statement (annual, 2025-12-31) — Pretax Income: -1072045.00
CNRI.V income_statement (quarterly, 2025-12-31) — Pretax Income: -234984.00
CNRI.V cash_flow (annual, 2025-12-31) — Purchase Of PPE: -18000.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
CNRI.V balance_sheet (annual, 2025-12-31) — Receivables: 57505.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Receivables: 57505.00
CNRI.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 24213.00
CNRI.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6053.00
CNRI.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 24213.00
CNRI.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6053.00
CNRI.V income_statement (annual, 2025-12-31) — Rent And Landing Fees: 75360.00
CNRI.V income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 18840.00
CNRI.V income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 75360.00
CNRI.V income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 18840.00
CNRI.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -519550.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
CNRI.V cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -76618.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1.00
CNRI.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -15352851.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -15352851.00
CNRI.V income_statement (annual, 2025-12-31) — Salaries And Wages: 46978.00
CNRI.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 11841.00
CNRI.V income_statement (annual, 2025-12-31) — Selling General And Administration: 935651.00
CNRI.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 211273.00
CNRI.V balance_sheet (annual, 2025-12-31) — Share Issued: 114320317.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 114320317.00
CNRI.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 46978.00
CNRI.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 11841.00
CNRI.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 42625967.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 42625967.00
CNRI.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 42625967.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 42625967.00
CNRI.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CNRI.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CNRI.V income_statement (annual, 2025-12-31) — Tax Provision: -360179.00
CNRI.V income_statement (quarterly, 2025-12-31) — Tax Provision: 28463.00
CNRI.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.34
CNRI.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
CNRI.V balance_sheet (annual, 2025-12-31) — Taxes Receivable: 57505.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 57505.00
CNRI.V balance_sheet (annual, 2025-12-31) — Total Assets: 45926568.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 45926568.00
CNRI.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 42625967.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 42625967.00
CNRI.V balance_sheet (annual, 2025-12-31) — Total Debt: 0.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 0.00
CNRI.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 42625967.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 42625967.00
CNRI.V income_statement (annual, 2025-12-31) — Total Expenses: 1031864.00
CNRI.V income_statement (quarterly, 2025-12-31) — Total Expenses: 235326.00
CNRI.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3300601.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3300601.00
CNRI.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 45718049.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 45718049.00
CNRI.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2255321.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2255321.00
CNRI.V balance_sheet (annual, 2025-12-31) — Working Capital: -836761.00
CNRI.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -836761.00
CNS balance_sheet (annual, 2021-12-31) — Cash Financial: 184373000.00
CNS cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -1440000.00
CNS cash_flow (annual, 2021-12-31) — Depreciation: 16064000.00
CNS cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 16064000.00
CNS income_statement (annual, 2021-12-31) — Interest Income: 2877000.00
CNS income_statement (annual, 2021-12-31) — Interest Income Non Operating: 2877000.00
CNS income_statement (annual, 2021-12-31) — Net Interest Income: 2877000.00
CNS income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: 2877000.00
CNS balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 89143000.00
CNS income_statement (annual, 2022-12-31) — +Operating Expense: 59209000.00
CNS income_statement (annual, 2022-12-31) — +Total Revenue: 573724000.00
CNS balance_sheet (annual, 2022-12-31) — Accounts Payable: 8421000.00
CNS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 66676000.00
CNS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -45414000.00
CNS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 769373000.00
CNS cash_flow (annual, 2022-12-31) — Amortization Of Securities: -115000.00
CNS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 157646000.00
CNS income_statement (annual, 2022-12-31) — Basic Average Shares: 48781000.00
CNS income_statement (annual, 2022-12-31) — Basic EPS: 3.51
CNS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 185356000.00
CNS cash_flow (annual, 2022-12-31) — Capital Expenditure: -4223000.00
CNS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 138809000.00
CNS balance_sheet (annual, 2022-12-31) — Capital Stock: 551000.00
CNS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 247418000.00
CNS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 262707000.00
CNS cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -107352000.00
CNS balance_sheet (annual, 2022-12-31) — Cash Financial: 247418000.00
CNS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 8975000.00
CNS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2857000.00
CNS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 61680000.00
CNS cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -1403000.00
CNS cash_flow (annual, 2022-12-31) — Change In Dividend Payable: -1762000.00
CNS cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -15036000.00
CNS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -168660000.00
CNS cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -10382000.00
CNS cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -1403000.00
CNS cash_flow (annual, 2022-12-31) — Change In Payable: -13752000.00
CNS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -15155000.00
CNS cash_flow (annual, 2022-12-31) — Change In Receivables: 14195000.00
CNS cash_flow (annual, 2022-12-31) — Change In Tax Payable: -15036000.00
CNS cash_flow (annual, 2022-12-31) — Change In Working Capital: -180002000.00
CNS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 15827000.00
CNS cash_flow (annual, 2022-12-31) — Changes In Cash: 67798000.00
CNS balance_sheet (annual, 2022-12-31) — Common Stock: 551000.00
CNS cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -107352000.00
CNS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 337554000.00
CNS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CNS cash_flow (annual, 2022-12-31) — Common Stock Payments: -26815000.00
CNS income_statement (annual, 2022-12-31) — Cost Of Revenue: 291759000.00
CNS balance_sheet (annual, 2022-12-31) — Current Assets: 331463000.00
CNS balance_sheet (annual, 2022-12-31) — Current Liabilities: 17006000.00
CNS cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1199000.00
CNS cash_flow (annual, 2022-12-31) — Deferred Tax: -1199000.00
CNS cash_flow (annual, 2022-12-31) — Depreciation: 17350000.00
CNS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 5667000.00
CNS income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 4383000.00
CNS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 5667000.00
CNS income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 4383000.00
CNS income_statement (annual, 2022-12-31) — Diluted Average Shares: 49297000.00
CNS income_statement (annual, 2022-12-31) — Diluted EPS: 3.47
CNS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 171042000.00
CNS income_statement (annual, 2022-12-31) — EBIT: 222756000.00
CNS income_statement (annual, 2022-12-31) — EBITDA: 228423000.00
CNS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -4440000.00
CNS balance_sheet (annual, 2022-12-31) — Employee Benefits: 77764000.00
CNS cash_flow (annual, 2022-12-31) — End Cash Position: 248714000.00
CNS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 8975000.00
CNS cash_flow (annual, 2022-12-31) — Free Cash Flow: 57457000.00
CNS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 25106000.00
CNS income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -25859000.00
CNS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -10784000.00
CNS income_statement (annual, 2022-12-31) — General And Administrative Expense: 54826000.00
CNS balance_sheet (annual, 2022-12-31) — Goodwill: 17799000.00
CNS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 19049000.00
CNS balance_sheet (annual, 2022-12-31) — Gross PPE: 190601000.00
CNS income_statement (annual, 2022-12-31) — Gross Profit: 281965000.00
CNS balance_sheet (annual, 2022-12-31) — Income Tax Payable: 7750000.00
CNS income_statement (annual, 2022-12-31) — Interest Income: 6818000.00
CNS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 6818000.00
CNS balance_sheet (annual, 2022-12-31) — Invested Capital: 337554000.00
CNS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2857000.00
CNS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 157646000.00
CNS balance_sheet (annual, 2022-12-31) — Investments And Advances: 157666000.00
CNS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CNS balance_sheet (annual, 2022-12-31) — Leases: 15466000.00
CNS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 138809000.00
CNS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 138809000.00
CNS balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 20000.00
CNS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 30552000.00
CNS balance_sheet (annual, 2022-12-31) — Minority Interest: 89389000.00
CNS income_statement (annual, 2022-12-31) — Minority Interests: 21556000.00
CNS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -26815000.00
CNS cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 1587000.00
CNS income_statement (annual, 2022-12-31) — Net Income: 171042000.00
CNS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 171042000.00
CNS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 149486000.00
CNS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 171042000.00
CNS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 171042000.00
CNS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 149486000.00
CNS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 149486000.00
CNS income_statement (annual, 2022-12-31) — Net Interest Income: 6818000.00
CNS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 1366000.00
CNS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 6818000.00
CNS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 142099000.00
CNS balance_sheet (annual, 2022-12-31) — Net PPE: 145187000.00
CNS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4223000.00
CNS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 318505000.00
CNS income_statement (annual, 2022-12-31) — Normalized EBITDA: 254282000.00
CNS income_statement (annual, 2022-12-31) — Normalized Income: 191289597.00
CNS cash_flow (annual, 2022-12-31) — Operating Cash Flow: 61680000.00
CNS cash_flow (annual, 2022-12-31) — Operating Gains Losses: 26693000.00
CNS income_statement (annual, 2022-12-31) — Operating Income: 222756000.00
CNS income_statement (annual, 2022-12-31) — Operating Revenue: 571222000.00
CNS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 48722797.00
CNS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -10784000.00
CNS income_statement (annual, 2022-12-31) — Other Gand A: 54826000.00
CNS income_statement (annual, 2022-12-31) — Other Income Expense: -25859000.00
CNS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1250000.00
CNS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 11798000.00
CNS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 20014000.00
CNS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 12857000.00
CNS balance_sheet (annual, 2022-12-31) — Other Payable: 835000.00
CNS balance_sheet (annual, 2022-12-31) — Other Properties: 144583000.00
CNS balance_sheet (annual, 2022-12-31) — Other Receivables: 2080000.00
CNS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 15289000.00
CNS balance_sheet (annual, 2022-12-31) — Payables: 17006000.00
CNS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 17006000.00
CNS income_statement (annual, 2022-12-31) — Pretax Income: 196897000.00
CNS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1043000.00
CNS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CNS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -145345000.00
CNS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4223000.00
CNS balance_sheet (annual, 2022-12-31) — Receivables: 68756000.00
CNS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 290475000.00
CNS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 5667000.00
CNS cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -26815000.00
CNS balance_sheet (annual, 2022-12-31) — Retained Earnings: -171417000.00
CNS cash_flow (annual, 2022-12-31) — Sale Of Investment: 146711000.00
CNS income_statement (annual, 2022-12-31) — Selling General And Administration: 54826000.00
CNS balance_sheet (annual, 2022-12-31) — Share Issued: 55051975.00
CNS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 49352000.00
CNS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 337554000.00
CNS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 318505000.00
CNS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -5611403.00
CNS income_statement (annual, 2022-12-31) — Tax Provision: 47411000.00
CNS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
CNS balance_sheet (annual, 2022-12-31) — Total Assets: 673379000.00
CNS balance_sheet (annual, 2022-12-31) — Total Capitalization: 337554000.00
CNS balance_sheet (annual, 2022-12-31) — Total Debt: 138809000.00
CNS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 426943000.00
CNS income_statement (annual, 2022-12-31) — Total Expenses: 350968000.00
CNS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 246436000.00
CNS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 341916000.00
CNS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 229430000.00
CNS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 215938000.00
CNS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 7750000.00
CNS income_statement (annual, 2022-12-31) — Total Unusual Items: -25859000.00
CNS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -25859000.00
CNS balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 6329178.00
CNS balance_sheet (annual, 2022-12-31) — Treasury Stock: 250169000.00
CNS balance_sheet (annual, 2022-12-31) — Working Capital: 314457000.00
CNS income_statement (annual, 2023-12-31) — +Operating Expense: 70809000.00
CNS income_statement (annual, 2023-12-31) — +Total Revenue: 504255000.00
CNS balance_sheet (annual, 2023-12-31) — Accounts Payable: 10144000.00
CNS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 68889000.00
CNS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -49591000.00
CNS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 818269000.00
CNS cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1954000.00
CNS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 180958000.00
CNS income_statement (annual, 2023-12-31) — Basic Average Shares: 49308000.00
CNS income_statement (annual, 2023-12-31) — Basic EPS: 2.62
CNS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 248714000.00
CNS cash_flow (annual, 2023-12-31) — Capital Expenditure: -56986000.00
CNS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 140408000.00
CNS balance_sheet (annual, 2023-12-31) — Capital Stock: 558000.00
CNS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 187442000.00
CNS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 265438000.00
CNS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -112446000.00
CNS balance_sheet (annual, 2023-12-31) — Cash Financial: 187442000.00
CNS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -119052000.00
CNS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -114776000.00
CNS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 171961000.00
CNS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -11382000.00
CNS cash_flow (annual, 2023-12-31) — Change In Dividend Payable: 1723000.00
CNS cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -2743000.00
CNS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -26528000.00
CNS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 20593000.00
CNS cash_flow (annual, 2023-12-31) — Change In Payable: -911000.00
CNS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -12293000.00
CNS cash_flow (annual, 2023-12-31) — Change In Receivables: -4031000.00
CNS cash_flow (annual, 2023-12-31) — Change In Tax Payable: -2743000.00
CNS cash_flow (annual, 2023-12-31) — Change In Working Capital: -22259000.00
CNS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1426000.00
CNS cash_flow (annual, 2023-12-31) — Changes In Cash: -61867000.00
CNS balance_sheet (annual, 2023-12-31) — Common Stock: 558000.00
CNS cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -112446000.00
CNS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 381228000.00
CNS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CNS cash_flow (annual, 2023-12-31) — Common Stock Payments: -21536000.00
CNS income_statement (annual, 2023-12-31) — Cost Of Revenue: 254351000.00
CNS balance_sheet (annual, 2023-12-31) — Current Assets: 339004000.00
CNS balance_sheet (annual, 2023-12-31) — Current Liabilities: 15460000.00
CNS cash_flow (annual, 2023-12-31) — Deferred Income Tax: 537000.00
CNS cash_flow (annual, 2023-12-31) — Deferred Tax: 537000.00
CNS cash_flow (annual, 2023-12-31) — Depreciation: 19638000.00
CNS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 5142000.00
CNS income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 4105000.00
CNS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 5142000.00
CNS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 4105000.00
CNS income_statement (annual, 2023-12-31) — Diluted Average Shares: 49553000.00
CNS income_statement (annual, 2023-12-31) — Diluted EPS: 2.60
CNS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 129049000.00
CNS income_statement (annual, 2023-12-31) — EBIT: 179095000.00
CNS income_statement (annual, 2023-12-31) — EBITDA: 184237000.00
CNS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2756000.00
CNS balance_sheet (annual, 2023-12-31) — Employee Benefits: 66382000.00
CNS cash_flow (annual, 2023-12-31) — End Cash Position: 189603000.00
CNS cash_flow (annual, 2023-12-31) — Financing Cash Flow: -119052000.00
CNS cash_flow (annual, 2023-12-31) — Free Cash Flow: 114975000.00
CNS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -4291000.00
CNS income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1156000.00
CNS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -7708000.00
CNS income_statement (annual, 2023-12-31) — General And Administrative Expense: 66704000.00
CNS balance_sheet (annual, 2023-12-31) — Goodwill: 18145000.00
CNS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 19395000.00
CNS balance_sheet (annual, 2023-12-31) — Gross PPE: 219229000.00
CNS income_statement (annual, 2023-12-31) — Gross Profit: 249904000.00
CNS balance_sheet (annual, 2023-12-31) — Income Tax Payable: 5115000.00
CNS income_statement (annual, 2023-12-31) — Interest Income: 14618000.00
CNS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 14618000.00
CNS balance_sheet (annual, 2023-12-31) — Invested Capital: 381228000.00
CNS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -114776000.00
CNS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 180958000.00
CNS balance_sheet (annual, 2023-12-31) — Investments And Advances: 180974000.00
CNS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CNS balance_sheet (annual, 2023-12-31) — Leases: 59260000.00
CNS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 140408000.00
CNS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 140408000.00
CNS balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 16000.00
CNS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 41142000.00
CNS balance_sheet (annual, 2023-12-31) — Minority Interest: 111419000.00
CNS income_statement (annual, 2023-12-31) — Minority Interests: -7560000.00
CNS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -21536000.00
CNS cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -787000.00
CNS income_statement (annual, 2023-12-31) — Net Income: 129049000.00
CNS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 129049000.00
CNS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 136609000.00
CNS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 129049000.00
CNS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 129049000.00
CNS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 136609000.00
CNS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 136609000.00
CNS income_statement (annual, 2023-12-31) — Net Interest Income: 14618000.00
CNS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -57790000.00
CNS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 14618000.00
CNS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 13867000.00
CNS balance_sheet (annual, 2023-12-31) — Net PPE: 169638000.00
CNS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -56986000.00
CNS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 361833000.00
CNS income_statement (annual, 2023-12-31) — Normalized EBITDA: 183081000.00
CNS income_statement (annual, 2023-12-31) — Normalized Income: 128172888.33
CNS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 171961000.00
CNS cash_flow (annual, 2023-12-31) — Operating Gains Losses: -5078000.00
CNS income_statement (annual, 2023-12-31) — Operating Income: 179095000.00
CNS income_statement (annual, 2023-12-31) — Operating Revenue: 502229000.00
CNS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 49155447.00
CNS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -7708000.00
CNS income_statement (annual, 2023-12-31) — Other Gand A: 66704000.00
CNS income_statement (annual, 2023-12-31) — Other Income Expense: 1156000.00
CNS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1250000.00
CNS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 14496000.00
CNS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 27543000.00
CNS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 21657000.00
CNS balance_sheet (annual, 2023-12-31) — Other Payable: 201000.00
CNS balance_sheet (annual, 2023-12-31) — Other Properties: 118827000.00
CNS balance_sheet (annual, 2023-12-31) — Other Receivables: 4677000.00
CNS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 77996000.00
CNS balance_sheet (annual, 2023-12-31) — Payables: 15460000.00
CNS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 15460000.00
CNS income_statement (annual, 2023-12-31) — Pretax Income: 180251000.00
CNS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1063000.00
CNS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CNS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -169402000.00
CNS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -56986000.00
CNS balance_sheet (annual, 2023-12-31) — Receivables: 73566000.00
CNS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 253314000.00
CNS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 5142000.00
CNS cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -21536000.00
CNS balance_sheet (annual, 2023-12-31) — Retained Earnings: -158186000.00
CNS cash_flow (annual, 2023-12-31) — Sale Of Investment: 111612000.00
CNS income_statement (annual, 2023-12-31) — Selling General And Administration: 66704000.00
CNS balance_sheet (annual, 2023-12-31) — Share Issued: 55788720.00
CNS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 44468000.00
CNS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 381228000.00
CNS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 361833000.00
CNS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 279888.33
CNS income_statement (annual, 2023-12-31) — Tax Provision: 43642000.00
CNS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
CNS balance_sheet (annual, 2023-12-31) — Total Assets: 736554000.00
CNS balance_sheet (annual, 2023-12-31) — Total Capitalization: 381228000.00
CNS balance_sheet (annual, 2023-12-31) — Total Debt: 140408000.00
CNS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 492647000.00
CNS income_statement (annual, 2023-12-31) — Total Expenses: 325160000.00
CNS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 243907000.00
CNS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 397550000.00
CNS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 228447000.00
CNS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 164477000.00
CNS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 5115000.00
CNS income_statement (annual, 2023-12-31) — Total Unusual Items: 1156000.00
CNS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1156000.00
CNS balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 6633273.00
CNS balance_sheet (annual, 2023-12-31) — Treasury Stock: 271705000.00
CNS balance_sheet (annual, 2023-12-31) — Working Capital: 323544000.00
CNS cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
CNS cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
CNS income_statement (annual, 2024-12-31) — +Operating Expense: 69423000.00
CNS income_statement (annual, 2024-12-31) — +Total Revenue: 536761000.00
CNS balance_sheet (annual, 2024-12-31) — Accounts Payable: 8485000.00
CNS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 74389000.00
CNS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -25744000.00
CNS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -25744000.00
CNS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 943281000.00
CNS cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1083000.00
CNS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 208411000.00
CNS income_statement (annual, 2024-12-31) — Basic Average Shares: 50409000.00
CNS income_statement (annual, 2024-12-31) — Basic EPS: 3.00
CNS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 189603000.00
CNS cash_flow (annual, 2024-12-31) — Capital Expenditure: -11651000.00
CNS cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -1678000.00
CNS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 141115000.00
CNS balance_sheet (annual, 2024-12-31) — Capital Stock: 575000.00
CNS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 182974000.00
CNS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 309927000.00
CNS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -119181000.00
CNS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 18167000.00
CNS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -119712000.00
CNS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 96689000.00
CNS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 4667000.00
CNS cash_flow (annual, 2024-12-31) — Change In Dividend Payable: -1659000.00
CNS cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -162000.00
CNS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -100890000.00
CNS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -17307000.00
CNS cash_flow (annual, 2024-12-31) — Change In Payable: 23260000.00
CNS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 27927000.00
CNS cash_flow (annual, 2024-12-31) — Change In Receivables: -28311000.00
CNS cash_flow (annual, 2024-12-31) — Change In Tax Payable: -162000.00
CNS cash_flow (annual, 2024-12-31) — Change In Working Capital: -118581000.00
CNS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -6738000.00
CNS cash_flow (annual, 2024-12-31) — Changes In Cash: -4856000.00
CNS balance_sheet (annual, 2024-12-31) — Common Stock: 575000.00
CNS cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -119181000.00
CNS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 511711000.00
CNS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 68464000.00
CNS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CNS cash_flow (annual, 2024-12-31) — Common Stock Payments: -21106000.00
CNS income_statement (annual, 2024-12-31) — Cost Of Revenue: 275117000.00
CNS balance_sheet (annual, 2024-12-31) — Current Assets: 385790000.00
CNS balance_sheet (annual, 2024-12-31) — Current Liabilities: 15197000.00
CNS cash_flow (annual, 2024-12-31) — Deferred Income Tax: -297000.00
CNS cash_flow (annual, 2024-12-31) — Deferred Tax: -297000.00
CNS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 11169000.00
CNS income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 9288000.00
CNS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 11169000.00
CNS income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 9288000.00
CNS income_statement (annual, 2024-12-31) — Diluted Average Shares: 50938000.00
CNS income_statement (annual, 2024-12-31) — Diluted EPS: 2.97
CNS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 151265000.00
CNS income_statement (annual, 2024-12-31) — EBIT: 192221000.00
CNS income_statement (annual, 2024-12-31) — EBITDA: 203390000.00
CNS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1585000.00
CNS balance_sheet (annual, 2024-12-31) — Employee Benefits: 71049000.00
CNS cash_flow (annual, 2024-12-31) — End Cash Position: 183162000.00
CNS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 18167000.00
CNS cash_flow (annual, 2024-12-31) — Free Cash Flow: 85038000.00
CNS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -16582000.00
CNS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 17320000.00
CNS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -10025000.00
CNS income_statement (annual, 2024-12-31) — General And Administrative Expense: 60135000.00
CNS balance_sheet (annual, 2024-12-31) — Goodwill: 17506000.00
CNS balance_sheet (quarterly, 2024-12-31) — Goodwill: 17506000.00
CNS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 18756000.00
CNS balance_sheet (annual, 2024-12-31) — Gross PPE: 193548000.00
CNS income_statement (annual, 2024-12-31) — Gross Profit: 261644000.00
CNS balance_sheet (annual, 2024-12-31) — Income Tax Payable: 4601000.00
CNS balance_sheet (annual, 2024-12-31) — Invested Capital: 511711000.00
CNS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -119712000.00
CNS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 208411000.00
CNS balance_sheet (annual, 2024-12-31) — Investments And Advances: 208424000.00
CNS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 68464000.00
CNS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CNS balance_sheet (annual, 2024-12-31) — Leases: 51718000.00
CNS balance_sheet (quarterly, 2024-12-31) — Leases: 51718000.00
CNS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 141115000.00
CNS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 141115000.00
CNS balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 13000.00
CNS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 30422000.00
CNS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 30422000.00
CNS balance_sheet (annual, 2024-12-31) — Minority Interest: 63192000.00
CNS income_statement (annual, 2024-12-31) — Minority Interests: -11527000.00
CNS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 47358000.00
CNS cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 1238000.00
CNS income_statement (annual, 2024-12-31) — Net Income: 151265000.00
CNS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 151265000.00
CNS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 162792000.00
CNS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 151265000.00
CNS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 151265000.00
CNS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 162792000.00
CNS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 162792000.00
CNS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -108061000.00
CNS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 88890000.00
CNS balance_sheet (annual, 2024-12-31) — Net PPE: 167804000.00
CNS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -11651000.00
CNS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 492955000.00
CNS income_statement (annual, 2024-12-31) — Normalized EBITDA: 186070000.00
CNS income_statement (annual, 2024-12-31) — Normalized Income: 138032520.00
CNS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 96689000.00
CNS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -15344000.00
CNS income_statement (annual, 2024-12-31) — Operating Income: 192221000.00
CNS income_statement (annual, 2024-12-31) — Operating Revenue: 534545000.00
CNS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 50574641.00
CNS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -10025000.00
CNS income_statement (annual, 2024-12-31) — Other Gand A: 60135000.00
CNS income_statement (annual, 2024-12-31) — Other Income Expense: 17320000.00
CNS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1250000.00
CNS balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 1250000.00
CNS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 5732000.00
CNS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 31592000.00
CNS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 10102000.00
CNS balance_sheet (annual, 2024-12-31) — Other Payable: 2111000.00
CNS balance_sheet (annual, 2024-12-31) — Other Properties: 111408000.00
CNS balance_sheet (annual, 2024-12-31) — Other Receivables: 1474000.00
CNS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 126953000.00
CNS balance_sheet (annual, 2024-12-31) — Payables: 15197000.00
CNS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 15197000.00
CNS income_statement (annual, 2024-12-31) — Pretax Income: 209541000.00
CNS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1100000.00
CNS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CNS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CNS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -417459000.00
CNS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -11651000.00
CNS cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -1678000.00
CNS balance_sheet (annual, 2024-12-31) — Receivables: 75863000.00
CNS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 273236000.00
CNS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 11169000.00
CNS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -21106000.00
CNS balance_sheet (annual, 2024-12-31) — Retained Earnings: -129339000.00
CNS cash_flow (annual, 2024-12-31) — Sale Of Investment: 309398000.00
CNS income_statement (annual, 2024-12-31) — Selling General And Administration: 60135000.00
CNS balance_sheet (annual, 2024-12-31) — Share Issued: 57492567.00
CNS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 52301000.00
CNS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 511711000.00